Inspirational message in sand
Ms Williams has endured a decade of chemotherapy and surgery following her 2003 diagnosis of mesothelioma – an internal cancer caused by inhaling asbestos particles.Source: www.topix.com Via newsmixx: home News
Japan Study Finds Standard Chemotherapy Still Best Hope for Mesothelioma
Results of a new study by researchers at Shizuoka Cancer Center and Juntendo University in Japan show chemotherapy is the best treatment for mesothelioma.
Investigation Report on China Pemetrexed Market, 2009-2018
Pemetrexed, originally developed by Eli Lilly and Company, is a multi-targeted antimetabolite antitumor drug.
Investigation Report on China Pemetrexed Market, 2009-2018
Pemetrexed, originally developed by Eli Lilly and Company, is a multi-targeted antimetabolite antitumor drug.Source: www.topix.com Via newsmixx: home News
Editorial: It’s time to eliminate the cigarette butt
University of Massachusetts students Elizabeth M. Weisberger of Boston, 19, left, and Tami R. Glaser of Albany, NY, 21 picking up cigarette butts on the UMass-Amherst campus as volunteers for “No Butts About It Day” at the university in this 2007 photo…
Editorial: It’s time to eliminate the cigarette butt
University of Massachusetts students Elizabeth M. Weisberger of Boston, 19, left, and Tami R. Glaser of Albany, NY, 21 picking up cigarette butts on the UMass-Amherst campus as volunteers for “No Butts About It Day” at the university in this 2007 photo…
Governor Signs Asbestos Lawsuit Bill Despite Veterans’ Opposition
There are thousands of asbestos-related deaths in the U.S. every year. Thursday, Governor Walker signed a bill that changes the process for bringing asbestos exposure lawsuits in Wisconsin.
Governor Signs Asbestos Lawsuit Bill Despite Veterans’ Opposition
There are thousands of asbestos-related deaths in the U.S. every year. Thursday, Governor Walker signed a bill that changes the process for bringing asbestos exposure lawsuits in Wisconsin.Source: www.topix.com Via newsmixx: home News
Five Prime Therapeutics Announces Upcoming Presentations at the 2014…
Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that data related to FP-1039 , an FGF ligand trap in a global,…
Five Prime Therapeutics Announces Upcoming Presentations at the 2014…
Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that data related to FP-1039 , an FGF ligand trap in a global,…
Mesothelioma Sufferer May Get More From Ford
Ford Motor Co. may owe punitive damages to a mechanic whose contact with asbestos gave him mesothelioma, a California appeals court ruled Wednesday.
Mesothelioma Sufferer May Get More From Ford
Ford Motor Co. may owe punitive damages to a mechanic whose contact with asbestos gave him mesothelioma, a California appeals court ruled Wednesday.Source: www.topix.com Via newsmixx: home News
New study suggests breast cancer drug may shrink mesothelioma tumors
After new evidence surfaced suggesting the enzyme aromatase is associated with malignant mesothelioma, Italian scientists began testing breast cancer drug Aromasin (exemestane) on mice and mesothelioma cells. Designed to inhibit aromatase, Aromasin curbs cell growth in breast cancer patients by helping reduce the amount of estrogen in the body. In the mesothelioma cells and mice, […]
Italy’s MolMed close to announcing cancer drug results
Italy’s MolMed is close to presenting results from Phase III clinical trials of a new cancer treatment that could represent a turning point for the biotech company, its founder said on Wednesday.
Italy’s MolMed close to announcing cancer drug results
Italy’s MolMed is close to presenting results from Phase III clinical trials of a new cancer treatment that could represent a turning point for the biotech company, its founder said on Wednesday.Source: www.topix.com Via newsmixx: home News